CASI Pharmaceuticals, Inc. funding
CASI Pharmaceuticals, Inc., a pharmaceuticals company based in Beijing, China (founded 2023), filed a Form D with the SEC on April 28, 2026 and reported $5M raised. It filed 4 new offerings in this period, totaling $20M.
Amount raised$5M
Offering size$5M
Filed with the SECApril 28, 2026
First saleApril 17, 2026
IndustryPharmaceuticals
SecuritiesDebt, Options or warrants, Security to be acquired on exercise
LocationBeijing, China
Founded2023
Entity typeOther
Investors so far1
Minimum investment—
Revenue range$5,000,001 - $25,000,000
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 28
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| April 28, 2026 | $5M | $5M | Debt, Options or warrants, Security to be acquired on exercise |
| February 26, 2026 | $5M | $5M | Debt, Options or warrants, Security to be acquired on exercise |
| January 28, 2026 | $5M | $5M | Debt, Options or warrants, Security to be acquired on exercise |
| January 28, 2026 | $5M | $5M | Debt, Options or warrants, Security to be acquired on exercise |
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology